Data / Form D filings / SteadyMed Ltd.
SteadyMed Ltd.: Form D filings
SteadyMed Ltd., a pharmaceuticals company in Rehovot, Israel, filed 2 Form D notices with the SEC between 2016 and 2017. The latest, on May 8, 2017, reports $30 million sold of a $30 million offering to 19 investors.
Find out what SteadyMed Ltd. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5 OPPENHEIMER STREET, Rehovot, Israel, 76701
- Phone
- (925) 272-4991
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Israel
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1619087
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 8, 2017 | New notice | $30,000,617 | $30,000,617 | $0 | 19 | Apr 25, 2017 | sec.gov |
| Aug 17, 2016 | New notice | $32,000,000 | $21,333,322 | $10,666,678 | 13 | Aug 4, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Brian W. Stark | Director | |
| Elizabeth W. Cermak | Director | |
| Stephen W. Farr | Director | |
| Ron W. Ginor | Director | |
| Donald W. Huffman | Director | |
| David W. Nassif | Executive Officer | |
| Keith W. Bank | Director | |
| Jonathan Rigby | Executive Officer, Director |
Every Form D from the week of May 8, 2017 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what SteadyMed Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.